Kakao Healthcare has unveiled its latest AI-driven mobile diabetes management app.
Called PASTA (Personalised, Accessible, Supportive, Tech-enabled, and Affordable), the app currently links to two CGM devices: CareSens Air by local manufacturer i-SENS and Dexcom's G7. The app will also pair with the Mallya smart cap for insulin pens by the second quarter.
Once the CGM device is linked, the app...
A government-funded initiative to seamlessly connect hospitals, government, insurers, and medical device manufacturers in the whole care process based on digital therapeutics and big data has commenced at Yonsei University Health System.
Yonsei's Severance Hospital recently started prescribing the insomnia DTx Somzz through the integrated platform called Connect-DTx.
HOW IT WORKS
Connect-DTx can...
Samsung to integrate Lunit's AI in premium X-ray devices
South Korean medical AI provider Lunit has signed a three-year supply contract with Samsung Electronics.
The deal is for the integration of Lunit's two chest X-ray AI solutions – Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage – into Samsung's line of premium X-ray devices.
According to a press release, the AI-integrated X-ray devices will...
New player in digital diabetes management
Diabetes app Smit.fit from India and Qatar-based digital therapeutics (DTx) company Droobi Health have announced their merger.
The combined entity called DroobiSmit, headquartered in Singapore, aims to be a leading diabetes solution provider in the Middle East and South Asia regions. It will offer personalised solutions for people with pre-diabetes,...
Meds tracking live on Samsung Health
Samsung Electronics has started rolling out a new Medications tracking feature on the Samsung Health app to help users manage their medications and improve adherence.
The feature helps users keep track of their prescription and over-the-counter medications. It also provides users detailed information about their medications, including potential side effects...
Indian AI drug discovery firm gets $1M to focus on rare diseases
Peptris Technologies from Bangalore, India has received $1 million in pre-seed funding in a round led by Speciale Invest.
In a statement, the AI-driven drug discovery company said it will use its fresh funds to expand its research scope to cover rare diseases, adding to its existing work in cancer and inflammation.
Cipla raises...
Neurophet scores $15M in Series C funding, announces 2024 IPO
South Korean company Neurophet, a provider of brain image analysis software, has raised 20 billion won ($15 million) in a Series C funding round participated by institutional investors, such as KB Securities, Mirae Asset Securities, and IBK Industrial Bank of Korea.
This brings its total investments since its founding in 2016 to 50...
Shareholders of KOSDAQ-listed Lunit have recently participated in the company's recent capital raise, paying-in $150 million to fund its development of "next-generation" products and further expansion in the West.
Meanwhile, the AI cancer diagnostics solutions provider obtained its third 510(k) clearance from the United States Food and Drug Administration.
WHAT IT'S FOR
In a company disclosure,...
Jolly Good announces new palliative care VR training module
Jolly Good in the United States, in partnership with Harvard-affiliated Brigham and Women’s Hospital, has developed a new VR training module in palliative care communication.
They came up with the VR module to help medical professionals acquire the necessary communication skills to provide care to terminally ill patients and their...
South Korean health tech startup Sky Labs has raised 20.7 billion won ($15.3 million) in a Series C funding round led by the government-run Korea Development Bank.
K2 Investment Partners, Devsisters Ventures, SJG Partners, and OpenWater Investment also joined the investing round.
This brings its total investment to 54.8 billion won ($40.5 million). It last raised $20 million in a Series B round...
